Although Virginia Gov Terry McAuliffe failed to pass a Medicaid expansion plan during his first year in office, the governor's health secretary has indicated that the fight will begin again.
The push for Medicaid expansion in Virginia is being renewed this week. Although Gov Terry McAuliffe failed during his first year in office to successfully pass a plan that would extend Medicaid to 400,000 uninsured Virginians, the governor's health secretary has indicated that the fight for Medicaid expansion is back on the table again, according to the Washington Post.
Gov McAuliffe is expected to present his plan Wednesday morning. According to the proposal, the program would save $100 million in 2016 and that money would be set aside for future use and would not be used by the state to close its $322 million shortfall.
While Virginia House Republicans are strongly opposed to expanding Medicaid, the governor is winning points with some liberals by refusing to give up the fight, the Post reports.
See the full article: http://wapo.st/13tRgZt
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Health Care Utilization and Cost of Diagnostic Testing for Respiratory Infections
September 17th 2025Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved value in patient care.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Drug Interactions With Ibrutinib Common, Linked to Higher Infection Risk in CLL
September 16th 2025Drug interactions with ibrutinib may not shorten survival when managed carefully, though the significant increase in infection-related hospitalizations tied to CYP3A inhibitors signals an urgent need for closer monitoring, dose adjustment, and proactive infection prevention strategies.
Read More